These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9832944

  • 1. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
    Pinna A, Di Chiara G.
    Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
    [Abstract] [Full Text] [Related]

  • 2. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 3. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan 28; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 4. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
    Morelli M, Fenu S, Pinna A, Di Chiara G.
    J Pharmacol Exp Ther; 1992 Jan 28; 260(1):402-8. PubMed ID: 1346165
    [Abstract] [Full Text] [Related]

  • 5. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Jan 28; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 6. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats.
    Spina L, Longoni R, Mulas A, Chang KJ, Di Chiara G.
    Behav Pharmacol; 1998 Feb 28; 9(1):1-8. PubMed ID: 9832942
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 28; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 8. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 9. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 01; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 10. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 01; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 11. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
    Morelli M, Fenu S, Carta A, Di Chiara G.
    Behav Brain Res; 1996 Sep 01; 79(1-2):93-100. PubMed ID: 8883820
    [Abstract] [Full Text] [Related]

  • 12. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC, Chase TN, Engber TM.
    J Pharmacol Exp Ther; 1993 Dec 01; 267(3):1454-9. PubMed ID: 7903390
    [Abstract] [Full Text] [Related]

  • 13. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Dec 01; 263(3):1454-63. PubMed ID: 1361576
    [Abstract] [Full Text] [Related]

  • 14. Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown.
    LaHoste GJ, Ruskin DN, Marshall JF.
    Brain Res; 1996 Jul 22; 728(1):97-104. PubMed ID: 8864302
    [Abstract] [Full Text] [Related]

  • 15. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
    Acquas E, Fenu S, Loddo P, Di Chiara G.
    Behav Brain Res; 1999 Sep 22; 103(2):219-28. PubMed ID: 10513590
    [Abstract] [Full Text] [Related]

  • 16. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
    Popoli P, Pèzzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferré S.
    Neuropsychopharmacology; 2001 Oct 22; 25(4):505-13. PubMed ID: 11557164
    [Abstract] [Full Text] [Related]

  • 17. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 22; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 18. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
    Ikeda H, Kotani A, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2007 Dec 22; 577(1-3):64-70. PubMed ID: 17884038
    [Abstract] [Full Text] [Related]

  • 19. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 20. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Synapse; 2008 May 15; 62(5):345-51. PubMed ID: 18297692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.